Abstract
Sarcoidosis is a systemic granulomatous disorder of unknown etiology, which involves the lung, eye, liver, and other organs. Vascular endothelial growth factor (VEGF) is a major regulator of angiogenesis involved in an important role in the development of granuloma. However, only a limited number of studies have reported on the relationship between serum VEGF values and the clinical status of sarcoidosis. Concentrations of serum VEGF were determined in 33 patients with sarcoidosis. We investigated the correlation between serum VEGF values and extent of disease, prognosis, and radiographic stage compared with serum angiotensin converting enzyme (ACE) values as another candidate. Concentrations of serum VEGF in patients who received corticosteroid treatment were significantly higher than those of patients with spontaneous remission (p < 0.05). In addition, serum VEGF values in patients with extrathoracic involvements were significantly higher than those of patients with sarcoid lesions limited to the thoracic space (p < 0.05), accompanied by a tendency to increase the number of organs involved. The values of serum ACE revealed no relationship to the values of serum VEGF, administration of corticosteroid, or extrathoracic involvements. We concluded that serum VEGF values in patients with sarcoidosis is a predictive factor in determining extrathoracic organ involvements and as a parameter for deciding the necessity of treatment with corticosteroid. Serum VEGF might be a useful marker as a prognostic indicator in sarcoidosis.
Similar content being viewed by others
References
S Nagai M Shigematsu K Hamada T Izumi (1999) ArticleTitleClinical courses and prognoses of pulmonary sarcoidosis. Curr Opin Pulm Med 5 293–298 Occurrence Handle10.1097/00063198-199909000-00005 Occurrence Handle1:STN:280:DyaK1MzptVKgtg%3D%3D Occurrence Handle10461533
HF Dvorak LF Brown M Detmar AM Dvorak (1995) ArticleTitleVascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 1029–1039 Occurrence Handle1:CAS:528:DyaK2MXmt1Kkt7g%3D Occurrence Handle7538264
S Takano Y Yoshii S Kondo H Suzuki T Maruno S Shirai T Nose (1996) ArticleTitleConcentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res 56 2185–2190 Occurrence Handle1:CAS:528:DyaK28Xis1ektbY%3D Occurrence Handle8616870
T Griga A Tromm J Spranger B May (1998) ArticleTitleIncreased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33 504–508 Occurrence Handle1:STN:280:DyaK1czhtFehtg%3D%3D Occurrence Handle9648990
W Matsuyama T Hashiguchi K Matsumuro F Iwami Y Hirotsu M Kawabata K Arimura M Osame (2000) ArticleTitleIncreased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med 162 1120–1122 Occurrence Handle1:STN:280:DC%2BD3cvotFaiug%3D%3D Occurrence Handle10988140
CG Li I Reynolds JM Ponting PJ Holt MC Hillarby S Kumar (1998) ArticleTitleSerum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener’s granulomatosis. Br J Rheumatol 37 1303–1306 Occurrence Handle10.1093/rheumatology/37.12.1303 Occurrence Handle1:STN:280:DyaK1M7jslCguw%3D%3D Occurrence Handle9973154
R Bragado E Bello L Requena G Renedo E Texeiro MV Alvarez MA Castilla C Caramelo (1999) ArticleTitleIncreased expression of vascular endothelial growth factor in pyogenic granulomas. Acta Derm Venereol 79 422–425 Occurrence Handle10.1080/000155599750009834 Occurrence Handle1:CAS:528:DC%2BD3cXlt1yjuro%3D Occurrence Handle10598753
E Tolnay C Kuhnen B Voss T Wiethege KM Muller (1998) ArticleTitleExpression and localization of vascular endothelial growth factor and its receptor flt in pulmonary sarcoidosis. Virchows Arch 432 61–65 Occurrence Handle10.1007/s004280050135 Occurrence Handle1:CAS:528:DyaK1cXjtlSmtg%3D%3D Occurrence Handle9463589
GW Hunninghake U Costabel M Ando R Baughman JF Cordier R du Bois A Eklund M Kitaichi J Lynch G Rizzato C Rose O Selroos G Semenzato OP Sharma (1999) ArticleTitleATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16 149–173 Occurrence Handle1:STN:280:DC%2BD3c%2Fitl2isg%3D%3D Occurrence Handle10560120
KC Meyer A Cardoni ZZ Xiang (2000) ArticleTitleVascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 135 332–338 Occurrence Handle1:CAS:528:DC%2BD3cXjtVGks7k%3D Occurrence Handle10779049
K Iwai M Sekiguti Y Hosoda RA DeRemee HD Tazelaar OP Sharma A Maheshwari TI Noguchi (1994) ArticleTitleRacial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11 26–31 Occurrence Handle1:STN:280:ByuA3M%2FislY%3D Occurrence Handle8036339
E Yamaguchi A Itoh N Hizawa Y Kawakami (2001) ArticleTitleThe gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 119 753–761 Occurrence Handle10.1378/chest.119.3.753 Occurrence Handle1:CAS:528:DC%2BD3MXisFSmt7o%3D Occurrence Handle11243953
M Petrek J Drabek V Kolek J Zlamal KI Welsh M Bunce E Weigl R Du Bois (2000) ArticleTitleCC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162 1000–1003 Occurrence Handle1:STN:280:DC%2BD3cvotFWqug%3D%3D Occurrence Handle10988120
A Pietinalho K Furuya E Yamaguchi Y Kawakami O Selroos (1999) ArticleTitleThe angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 13 723–726 Occurrence Handle10.1034/j.1399-3003.1999.13d04.x Occurrence Handle1:STN:280:DyaK1M3ovVyktA%3D%3D Occurrence Handle10362030
H Tomita S Sato R Matsuda Y Sugiura H Kawaguchi T Niimi S Yoshida M Morishita (1999) ArticleTitleSerum lysozyme levels and clinical features of sarcoidosis. Lung 177 161–167 Occurrence Handle1:STN:280:DyaK1M3gvVyjtQ%3D%3D Occurrence Handle10192763
J Muller-Quernheim (1998) ArticleTitleSerum markers for the staging of disease activity of sarcoidosis and other interstitial lung diseases of unknown etiology. Sarcoidosis Vasc Diffuse Lung Dis 15 22–37 Occurrence Handle1:STN:280:DyaK1c3jtlGhtA%3D%3D Occurrence Handle9571999
U Costabel H Teschler (1997) ArticleTitleBiochemical changes in sarcoidosis. Clin Chest Med 18 827–842 Occurrence Handle1:STN:280:DyaK1c%2FnsFGrsA%3D%3D Occurrence Handle9413661
J Katada M Muramatsu I Hayashi M Tsutsumi Y Konishi M Majima (2002) ArticleTitleSignificance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther 302 949–956 Occurrence Handle10.1124/jpet.102.034231 Occurrence Handle1:CAS:528:DC%2BD38XmsF2hsLk%3D Occurrence Handle12183651
U Costabel (2001) ArticleTitleSarcoidosis: clinical update. Eur Respir J (suppl) 32 56s–68s Occurrence Handle1:STN:280:DC%2BD38%2FovVeksw%3D%3D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sekiya, M., Ohwada, A., Miura, K. et al. Serum Vascular Endothelial Growth Factor as a Possible Prognostic Indicator in Sarcoidosis . Lung 181, 259–265 (2003). https://doi.org/10.1007/s00408-003-1028-8
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00408-003-1028-8